US Archives - Page 6 of 157 - European Medical Journal

Researchers reviewing oncology study protocol for cancer clinical trials development in Latin America

Cancer Clinical Trials Development in Latin America Lags

Cancer clinical trials development in Latin America underperforms globally yet strengths could expand equitable evidence worldwide.

Lung cancer blood test using FT-IR microspectroscopy to identify a circulating tumour cell in a cytospun blood sample.

New Blood Test Detects Single Lung Cancer Cell

FT-IR microspectroscopy blood test detected a single circulating tumor cell in one patient with lung cancer, cytospun raw blood sample.

acupuncture or massage for patients with cancer

Acupuncture, Massage Ease Symptoms in Underserved Patients with Cancer

Patients with cancer given access to free acupuncture and massage treatments at a community center in East Harlem, New York, reported symptom relief and broad satisfaction with services in an evaluation study.

Medication dose chart concept

Abrocitinib Treatment Adjusted for Atopic Dermatitis

Abrocitinib treatment can be personalized in moderate-to-severe atopic dermatitis using flexible dosing to meet disease trajectory.

AMJ Dermatology 2 [Supplement 6] 2025

JAK inhibitors have expanded options for managing alopecia areata, but questions remain around patient selection, monitoring, and…

Alopecia Areata Cases and Considerations

Experts examine the clinical evidence for JAK inhibitors in long-term management of alopecia areata…

Updates in Early-Stage HER2+ Breast Cancer

Data presented at the European Society for Medical Oncology (ESMO) Congress 2025 signal a potential shift in the management of early-stage…

AMJ Oncology 2.1 [Supplement 5] 2025

Treatment for advanced non-small cell lung cancer (NSCLC) with activating mutations in HER2 relies on chemo-immunotherapy in the…

Targeting the First-Line in HER2-Mutant NSCLC

Treatment for advanced non-small cell lung cancer (NSCLC) with activating mutations in HER2 relies on chemo-immunotherapy in the…

AMJ Oncology 2.1 [Supplement 4] 2025

Data presented at the European Society for Medical Oncology (ESMO) Congress 2025 signal a potential shift in the management of early-stage…